|
|
| p803 |
TNF expressed by tumor-associated macrophages, but not microglia, can eliminate glioma |
Jiro Nakagawa, Masanao Saio, Noriyuki Tamakawa, Tatsuhiko Suwa, Alan B. Frey, Kenichi Nonaka, Naoki Umemura, Hisashi Imai, Guan-Feng Ouyang, Naoyuki Ohe, Hirohito Yano, Sinichi Yoshimura, Toru Iwama, Tsuyoshi Takami
|
|
|
|
| p873 |
The influence of tumor oxygenation on hypoxia imaging in murine squamous cell carcinoma using [64Cu]Cu-ATSM or [18F]Fluoromisonidazole positron emission tomography |
Ken-Ichiro Matsumoto, Lawrence Szajek, Murali C. Krishna, John A. Cook, Jurgen Seidel, Kelly Grimes, Joann Carson, Anastasia L. Sowers, Sean English, Michael V. Green, Stephen L. Bacharach, William C. Eckelman, James B. Mitchell
|
|
|
|
| p919 |
Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis |
Yoichi Mizutani, Hiroyuki Nakanishi, Yong Nan Li, Hiroki Matsubara, Kosuke Yamamoto, Nodoka Sato, Takumi Shiraishi, Terukazu Nakamura, Kazuya Mikami, Koji Okihara, Natsuki Takaha, Osamu Ukimura, Akihiro Kawauchi, Norio Nonomura, Benjamin Bonavida, Tsuneharu Miki
|
|
|
|
| p927 |
Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck |
Alexander Sauter, Charlotte Kloft, Silke Gronau, Felix Bogeschdorfer, Thomas Erhardt, Wolfram Golze, Carsten Schroen, Alexander Staab, Herbert Riechelmann, Karl Hoermann
|
|
|
|
|
|